SOL SpA
MIL:SOL
Intrinsic Value
SOL SpA engages in the production, research, and distribution of industrial and medicinal gases; door-to-door medical care; and related medical equipment. [ Read More ]
The intrinsic value of one SOL stock under the Base Case scenario is 22.62 EUR. Compared to the current market price of 33.6 EUR, SOL SpA is Overvalued by 33%.
Valuation Backtest
SOL SpA
Run backtest to discover the historical profit from buying and selling SOL stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
SOL SpA
Current Assets | 734.4m |
Cash & Short-Term Investments | 132.2m |
Receivables | 501.7m |
Other Current Assets | 100.4m |
Non-Current Assets | 1.1B |
Long-Term Investments | 39m |
PP&E | 739.5m |
Intangibles | 258.8m |
Other Non-Current Assets | 25.7m |
Current Liabilities | 390.5m |
Accounts Payable | 169.3m |
Accrued Liabilities | 79.1m |
Short-Term Debt | 59.4m |
Other Current Liabilities | 82.6m |
Non-Current Liabilities | 538.1m |
Long-Term Debt | 458.5m |
Other Non-Current Liabilities | 79.6m |
Earnings Waterfall
SOL SpA
Revenue
|
1.5B
EUR
|
Cost of Revenue
|
-404.3m
EUR
|
Gross Profit
|
1.1B
EUR
|
Operating Expenses
|
-855m
EUR
|
Operating Income
|
227.9m
EUR
|
Other Expenses
|
-82.2m
EUR
|
Net Income
|
145.7m
EUR
|
Free Cash Flow Analysis
SOL SpA
SOL Profitability Score
Profitability Due Diligence
SOL SpA's profitability score is 58/100. The higher the profitability score, the more profitable the company is.
Score
SOL SpA's profitability score is 58/100. The higher the profitability score, the more profitable the company is.
SOL Solvency Score
Solvency Due Diligence
SOL SpA's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Score
SOL SpA's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SOL Price Targets Summary
SOL SpA
According to Wall Street analysts, the average 1-year price target for SOL is 38.76 EUR with a low forecast of 38.38 EUR and a high forecast of 39.9 EUR.
Shareholder Return
SOL Price
SOL SpA
Average Annual Return | 16.56% |
Standard Deviation of Annual Returns | 31.31% |
Max Drawdown | -34% |
Market Capitalization | 3B EUR |
Shares Outstanding | 90 700 000 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
SOL SpA engages in the production, research, and distribution of industrial and medicinal gases; door-to-door medical care; and related medical equipment. The company is headquartered in Monza, Monza E Brianza. The company is also involved in the home care medical business. The Company’s product portfolio includes oxygen, nitrogen, hydrogen, argon, sulfur hexafluoride, carbon dioxide, ozone, helium and mixtures of medicinal gases, among others. Through its subsidiaries, the Company is involved in the provision of home care services, such as oxygen therapy, mechanical ventilation, diagnosis and care of obstructive sleep apnea syndrome, artificial nutrition, telemedicine, health assistance, and the prevention and treatment of skin ulcers. Additionally, it is engaged in the supply and management of medical and technological devices for home care. As of December 31, 2011, the Company had a number of subsidiaries, including Airsol BV, Biotechsol Srl, CTS Srl, Energetika ZJ doo, GTH Gaze Industriale SA, Cryolab Srl, GTS Shpk and Hydroenergy Shpk, among others.
Contact
IPO
Employees
Officers
The intrinsic value of one SOL stock under the Base Case scenario is 22.62 EUR.
Compared to the current market price of 33.6 EUR, SOL SpA is Overvalued by 33%.